Dr. Clewell has worked with industry, government, and academic thought leaders around the globe to identify tools and technologies that are needed to build confidence in this new era of toxicology and to develop a framework for chemical testing using primarily in vitro and in silico approaches.
This framework, which uses high-throughput screening approaches for chemical triage and biologically complex in vitro systems and computational pathway models to evaluate chemical dose-response, supports chemical decisions from early screening and prioritization to in-depth evaluation of dose-response and margins of exposure.
Dr. Clewell has worked with industry and government to provide practical examples of how these strategies may be used for decision making. As a consultant, Dr. Clewell supports clients in the application of New Approach Methods (NAMs) to chemical safety decisions.